Cardiac DNA Insight® - Genetic Testing for Heart Health


Cardiac DNA Insight® can help identify a patient’s propensity for increased risk of certain heart-related health conditions.

This report also examines eight classes of drugs that affect the cardiovascular system: anti-platelets, anti-coagulants, statins, stimulants, beta-blockers, ACE inhibitors, calcium channel blockers and hormone therapies. Cardiac DNA Insight® may be used to enhance the information provided in lipid tests that evaluate risk for cardiovascular disease.

Request More Information

Want to know more about this test?

Cardiac DNA Insight® provides information that allows the physician to:

  • Better monitor a patient’s specific health condition.
  • Prescribe a more optimal medication and dosage for a patient.
  • Suggest early lifestyle and diet interventions to help combat or prevent certain health conditions.
Cardiac DNA Insight Report Patient 3 up

Cardiac DNA Insight® analyzes a patient’s unique genetic markers, which influence a broad range of heart-related conditions, including ApoE, HDL and LDL cholesterol levels, and risks for hypertension and myocardial infarction. This simple saliva or blood-based test is supported by scientifically validated genetic testing technologies using clinically relevant markers and assays.

The Cardiac DNA Insight® genetic test reports on the following conditions and traits:

Heart Disease/Atrial Fibrillation

Atrial fibrillation

Beta-blockers, LVEF response

Caffeine metabolism

Coronary artery disease

Myocardial infarction

Simvastatin-induced myopathy

Verapamil and QTc interval

Peripheral Arterial Disease/Venous Thrombosis

Clopidogrel metabolism (Plavix)

Estrogen supplementation (risk of venous thrombosis)

Peripheral arterial disease

Venous thrombosis





Metoprolol metabolism

Perindopril (ACE inhibitor-therapeutic benefit)

Verapamil vs. atenolol (benefit of)

Cardiovascular Health

ApoE and cardiovascular disease

Genetic risk for decreased folate

Genetic risk for decreased HDL cholesterol

Genetic risk for elevated LDL cholesterol

Genetic risk for elevated triglycerides

Sickle cell anemia

Share this page with a friend: